SEC Form 4 · accession 0001354488-15-000704
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wen Tao Liu
Officer — Executive Chairman · Director
Period of report
Feb 11, 2015
Accepted (ET)
Feb 17, 2015 · 12:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF1 | $15.53 | Feb 11, 2015 | A | 33,667 | A | — | Dec 31, 2021 | Common Stock | 33,667 | 213,667 | D |
Explanation of responses
- F1This option vests over a period of three years according to the following schedule: 1/3 on December 31, 2015 and 1/3 on each anniversary thereafter.